nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—SHBG—semen—cervical cancer	0.076	0.123	CbGeAlD
Levonorgestrel—CYP19A1—semen—cervical cancer	0.0616	0.0993	CbGeAlD
Levonorgestrel—AR—semen—cervical cancer	0.0545	0.0879	CbGeAlD
Levonorgestrel—Dyspareunia—Topotecan—cervical cancer	0.0457	0.203	CcSEcCtD
Levonorgestrel—SRD5A1—renal system—cervical cancer	0.0357	0.0575	CbGeAlD
Levonorgestrel—SRD5A1—female reproductive system—cervical cancer	0.0286	0.046	CbGeAlD
Levonorgestrel—Pelvic pain—Topotecan—cervical cancer	0.0137	0.0611	CcSEcCtD
Levonorgestrel—PGR—epithelium—cervical cancer	0.0126	0.0203	CbGeAlD
Levonorgestrel—SHBG—endometrium—cervical cancer	0.0126	0.0202	CbGeAlD
Levonorgestrel—PGR—uterine cervix—cervical cancer	0.0125	0.0202	CbGeAlD
Levonorgestrel—PGR—decidua—cervical cancer	0.0119	0.0192	CbGeAlD
Levonorgestrel—SHBG—uterus—cervical cancer	0.0116	0.0186	CbGeAlD
Levonorgestrel—PGR—endometrium—cervical cancer	0.0113	0.0182	CbGeAlD
Levonorgestrel—PGR—uterus—cervical cancer	0.0104	0.0168	CbGeAlD
Levonorgestrel—SHBG—female reproductive system—cervical cancer	0.0104	0.0168	CbGeAlD
Levonorgestrel—CYP19A1—endometrium—cervical cancer	0.0102	0.0164	CbGeAlD
Levonorgestrel—AR—epithelium—cervical cancer	0.01	0.0162	CbGeAlD
Levonorgestrel—AR—uterine cervix—cervical cancer	0.00996	0.0161	CbGeAlD
Levonorgestrel—ESR1—epithelium—cervical cancer	0.00986	0.0159	CbGeAlD
Levonorgestrel—ESR1—uterine cervix—cervical cancer	0.00978	0.0158	CbGeAlD
Levonorgestrel—AR—decidua—cervical cancer	0.00949	0.0153	CbGeAlD
Levonorgestrel—SHBG—female gonad—cervical cancer	0.00946	0.0153	CbGeAlD
Levonorgestrel—SHBG—vagina—cervical cancer	0.0094	0.0152	CbGeAlD
Levonorgestrel—CYP19A1—uterus—cervical cancer	0.00938	0.0151	CbGeAlD
Levonorgestrel—PGR—female reproductive system—cervical cancer	0.00937	0.0151	CbGeAlD
Levonorgestrel—AR—renal system—cervical cancer	0.00932	0.015	CbGeAlD
Levonorgestrel—ESR1—decidua—cervical cancer	0.00932	0.015	CbGeAlD
Levonorgestrel—Dysmenorrhoea—Topotecan—cervical cancer	0.00919	0.0409	CcSEcCtD
Levonorgestrel—ESR1—renal system—cervical cancer	0.00915	0.0147	CbGeAlD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.00901	0.0582	CbGpPWpGaD
Levonorgestrel—AR—endometrium—cervical cancer	0.00901	0.0145	CbGeAlD
Levonorgestrel—ESR1—endometrium—cervical cancer	0.00884	0.0143	CbGeAlD
Levonorgestrel—AR—mammalian vulva—cervical cancer	0.00871	0.014	CbGeAlD
Levonorgestrel—PGR—female gonad—cervical cancer	0.00852	0.0137	CbGeAlD
Levonorgestrel—PGR—vagina—cervical cancer	0.00847	0.0137	CbGeAlD
Levonorgestrel—CYP19A1—female reproductive system—cervical cancer	0.00843	0.0136	CbGeAlD
Levonorgestrel—AR—uterus—cervical cancer	0.0083	0.0134	CbGeAlD
Levonorgestrel—ESR1—uterus—cervical cancer	0.00815	0.0131	CbGeAlD
Levonorgestrel—CYP19A1—female gonad—cervical cancer	0.00767	0.0124	CbGeAlD
Levonorgestrel—Neoplasm—Topotecan—cervical cancer	0.00755	0.0336	CcSEcCtD
Levonorgestrel—AR—female reproductive system—cervical cancer	0.00746	0.012	CbGeAlD
Levonorgestrel—AR—Notch-mediated HES/HEY network—YY1—cervical cancer	0.00736	0.0476	CbGpPWpGaD
Levonorgestrel—ESR1—female reproductive system—cervical cancer	0.00733	0.0118	CbGeAlD
Levonorgestrel—PGR—Nuclear Receptors—RARB—cervical cancer	0.00718	0.0464	CbGpPWpGaD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—PIAS3—cervical cancer	0.00713	0.0461	CbGpPWpGaD
Levonorgestrel—AR—female gonad—cervical cancer	0.00679	0.0109	CbGeAlD
Levonorgestrel—AR—vagina—cervical cancer	0.00675	0.0109	CbGeAlD
Levonorgestrel—ESR1—female gonad—cervical cancer	0.00667	0.0107	CbGeAlD
Levonorgestrel—ESR1—vagina—cervical cancer	0.00663	0.0107	CbGeAlD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.00569	0.0367	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00568	0.0367	CbGpPWpGaD
Levonorgestrel—PGR—lymph node—cervical cancer	0.00548	0.00883	CbGeAlD
Levonorgestrel—AR—Nuclear Receptors—RARB—cervical cancer	0.00547	0.0353	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.00529	0.0341	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.00527	0.034	CbGpPWpGaD
Levonorgestrel—CYP3A4—renal system—cervical cancer	0.0051	0.00823	CbGeAlD
Levonorgestrel—CYP19A1—Tryptophan metabolism—UBE3A—cervical cancer	0.00496	0.032	CbGpPWpGaD
Levonorgestrel—CYP19A1—lymph node—cervical cancer	0.00493	0.00795	CbGeAlD
Levonorgestrel—Weight increased—Topotecan—cervical cancer	0.00477	0.0212	CcSEcCtD
Levonorgestrel—Pneumonia—Topotecan—cervical cancer	0.0047	0.0209	CcSEcCtD
Levonorgestrel—Infestation—Topotecan—cervical cancer	0.00467	0.0208	CcSEcCtD
Levonorgestrel—Infestation NOS—Topotecan—cervical cancer	0.00467	0.0208	CcSEcCtD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—UBE3A—cervical cancer	0.0046	0.0297	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.00438	0.0283	CbGpPWpGaD
Levonorgestrel—AR—lymph node—cervical cancer	0.00437	0.00704	CbGeAlD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00432	0.0279	CbGpPWpGaD
Levonorgestrel—ESR1—lymph node—cervical cancer	0.00429	0.00691	CbGeAlD
Levonorgestrel—Haemoglobin—Topotecan—cervical cancer	0.00422	0.0188	CcSEcCtD
Levonorgestrel—ESR1—Nuclear Receptors—RARB—cervical cancer	0.00421	0.0272	CbGpPWpGaD
Levonorgestrel—Rhinitis—Topotecan—cervical cancer	0.00421	0.0187	CcSEcCtD
Levonorgestrel—Haemorrhage—Topotecan—cervical cancer	0.00419	0.0187	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Topotecan—cervical cancer	0.00417	0.0186	CcSEcCtD
Levonorgestrel—Pharyngitis—Topotecan—cervical cancer	0.00416	0.0185	CcSEcCtD
Levonorgestrel—CYP3A4—female reproductive system—cervical cancer	0.00409	0.00659	CbGeAlD
Levonorgestrel—Immune system disorder—Topotecan—cervical cancer	0.00379	0.0169	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Topotecan—cervical cancer	0.00378	0.0168	CcSEcCtD
Levonorgestrel—Alopecia—Topotecan—cervical cancer	0.00371	0.0165	CcSEcCtD
Levonorgestrel—Malnutrition—Topotecan—cervical cancer	0.00365	0.0162	CcSEcCtD
Levonorgestrel—Back pain—Topotecan—cervical cancer	0.00353	0.0157	CcSEcCtD
Levonorgestrel—Muscle spasms—Topotecan—cervical cancer	0.00351	0.0156	CcSEcCtD
Levonorgestrel—AR—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.0034	0.0219	CbGpPWpGaD
Levonorgestrel—Anaemia—Topotecan—cervical cancer	0.00337	0.015	CcSEcCtD
Levonorgestrel—Angioedema—Topotecan—cervical cancer	0.00334	0.0148	CcSEcCtD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00333	0.0215	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—UBE3A—cervical cancer	0.00325	0.021	CbGpPWpGaD
Levonorgestrel—Cough—Topotecan—cervical cancer	0.00319	0.0142	CcSEcCtD
Levonorgestrel—Chest pain—Topotecan—cervical cancer	0.00311	0.0138	CcSEcCtD
Levonorgestrel—Myalgia—Topotecan—cervical cancer	0.00311	0.0138	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00309	0.0137	CcSEcCtD
Levonorgestrel—Discomfort—Topotecan—cervical cancer	0.00307	0.0137	CcSEcCtD
Levonorgestrel—Infection—Topotecan—cervical cancer	0.00296	0.0132	CcSEcCtD
Levonorgestrel—Nervous system disorder—Topotecan—cervical cancer	0.00292	0.013	CcSEcCtD
Levonorgestrel—Skin disorder—Topotecan—cervical cancer	0.00289	0.0129	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Topotecan—cervical cancer	0.00288	0.0128	CcSEcCtD
Levonorgestrel—Anorexia—Topotecan—cervical cancer	0.00284	0.0126	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00272	0.0121	CcSEcCtD
Levonorgestrel—Dyspnoea—Topotecan—cervical cancer	0.00266	0.0118	CcSEcCtD
Levonorgestrel—Dyspepsia—Topotecan—cervical cancer	0.00262	0.0117	CcSEcCtD
Levonorgestrel—Decreased appetite—Topotecan—cervical cancer	0.00259	0.0115	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Topotecan—cervical cancer	0.00257	0.0114	CcSEcCtD
Levonorgestrel—Fatigue—Topotecan—cervical cancer	0.00257	0.0114	CcSEcCtD
Levonorgestrel—Pain—Topotecan—cervical cancer	0.00255	0.0113	CcSEcCtD
Levonorgestrel—Constipation—Topotecan—cervical cancer	0.00255	0.0113	CcSEcCtD
Levonorgestrel—AR—Notch-mediated HES/HEY network—HES1—cervical cancer	0.00251	0.0162	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Topotecan—cervical cancer	0.00244	0.0108	CcSEcCtD
Levonorgestrel—Urticaria—Topotecan—cervical cancer	0.00237	0.0105	CcSEcCtD
Levonorgestrel—ESR1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00236	0.0152	CbGpPWpGaD
Levonorgestrel—Abdominal pain—Topotecan—cervical cancer	0.00236	0.0105	CcSEcCtD
Levonorgestrel—Body temperature increased—Topotecan—cervical cancer	0.00236	0.0105	CcSEcCtD
Levonorgestrel—Hypersensitivity—Topotecan—cervical cancer	0.0022	0.00977	CcSEcCtD
Levonorgestrel—Asthenia—Topotecan—cervical cancer	0.00214	0.00951	CcSEcCtD
Levonorgestrel—Pruritus—Topotecan—cervical cancer	0.00211	0.00938	CcSEcCtD
Levonorgestrel—Diarrhoea—Topotecan—cervical cancer	0.00204	0.00907	CcSEcCtD
Levonorgestrel—Dizziness—Topotecan—cervical cancer	0.00197	0.00877	CcSEcCtD
Levonorgestrel—CYP19A1—FSH signaling pathway—MTOR—cervical cancer	0.0019	0.0123	CbGpPWpGaD
Levonorgestrel—Vomiting—Topotecan—cervical cancer	0.00189	0.00843	CcSEcCtD
Levonorgestrel—AR—Notch-mediated HES/HEY network—NOTCH1—cervical cancer	0.00189	0.0122	CbGpPWpGaD
Levonorgestrel—Rash—Topotecan—cervical cancer	0.00188	0.00836	CcSEcCtD
Levonorgestrel—Dermatitis—Topotecan—cervical cancer	0.00188	0.00835	CcSEcCtD
Levonorgestrel—Headache—Topotecan—cervical cancer	0.00187	0.0083	CcSEcCtD
Levonorgestrel—Nausea—Topotecan—cervical cancer	0.00177	0.00787	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—HES1—cervical cancer	0.00161	0.0104	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.0015	0.00971	CbGpPWpGaD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0015	0.0097	CbGpPWpGaD
Levonorgestrel—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.00145	0.00934	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	0.00144	0.00927	CbGpPWpGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—CD4—cervical cancer	0.00142	0.00914	CbGpPWpGaD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—CASP8—cervical cancer	0.0014	0.00904	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CA9—cervical cancer	0.0013	0.00841	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—TERT—cervical cancer	0.00126	0.00813	CbGpPWpGaD
Levonorgestrel—ESR1—LKB1 signaling events—MTOR—cervical cancer	0.00117	0.00758	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00116	0.00748	CbGpPWpGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—STAT3—cervical cancer	0.0011	0.00708	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—FGFR3—cervical cancer	0.00103	0.00668	CbGpPWpGaD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—CTNNB1—cervical cancer	0.00102	0.00659	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—RARB—cervical cancer	0.00098	0.00633	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00096	0.0062	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	0.000822	0.00531	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.000816	0.00527	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—MTOR—cervical cancer	0.000813	0.00525	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000781	0.00504	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—CTNNB1—cervical cancer	0.000754	0.00487	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—MTOR—cervical cancer	0.000752	0.00485	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—RARB—cervical cancer	0.000747	0.00482	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—MTOR—cervical cancer	0.000728	0.0047	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CTNNB1—cervical cancer	0.000704	0.00455	CbGpPWpGaD
Levonorgestrel—ESR1—LKB1 signaling events—TP53—cervical cancer	0.000692	0.00447	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000678	0.00438	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—STAT3—cervical cancer	0.000658	0.00425	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000649	0.00419	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—FGFR3—cervical cancer	0.000607	0.00392	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—EGFR—cervical cancer	0.000598	0.00386	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000583	0.00377	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—STAT3—cervical cancer	0.000581	0.00375	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—RARB—cervical cancer	0.000575	0.00372	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—EGFR—cervical cancer	0.000571	0.00369	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000561	0.00363	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000557	0.0036	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—MTHFR—cervical cancer	0.000529	0.00341	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000522	0.00337	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000513	0.00331	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—EGFR—cervical cancer	0.000511	0.0033	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.0005	0.00323	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000495	0.00319	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000494	0.00319	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TAAR6—cervical cancer	0.00049	0.00316	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000482	0.00311	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.00048	0.0031	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—RARB—cervical cancer	0.000472	0.00305	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TP53—cervical cancer	0.000468	0.00303	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000441	0.00285	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000433	0.00279	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000429	0.00277	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—MTOR—cervical cancer	0.000427	0.00276	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000425	0.00275	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000425	0.00274	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00041	0.00264	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000402	0.0026	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000395	0.00255	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000392	0.00253	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—WNT2—cervical cancer	0.000382	0.00247	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000381	0.00246	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000381	0.00246	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RARB—cervical cancer	0.00036	0.00232	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000337	0.00218	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKAP13—cervical cancer	0.000336	0.00217	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000329	0.00212	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000327	0.00211	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000324	0.0021	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000315	0.00204	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH2—cervical cancer	0.000313	0.00202	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000306	0.00198	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000302	0.00195	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—EGFR—cervical cancer	0.0003	0.00194	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—WNT5A—cervical cancer	0.00029	0.00187	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TAAR6—cervical cancer	0.000287	0.00186	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CA9—cervical cancer	0.000283	0.00183	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000283	0.00183	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RARB—cervical cancer	0.000277	0.00179	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000272	0.00176	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000253	0.00164	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.00025	0.00161	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH2—cervical cancer	0.000238	0.00154	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000236	0.00152	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—WNT2—cervical cancer	0.000224	0.00145	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.00021	0.00136	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH2—cervical cancer	0.000203	0.00131	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKAP13—cervical cancer	0.000197	0.00127	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH1—cervical cancer	0.000194	0.00125	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH2—cervical cancer	0.000183	0.00118	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—WNT5A—cervical cancer	0.00017	0.0011	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HES1—cervical cancer	0.000167	0.00108	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH1—cervical cancer	0.000147	0.000952	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TERT—cervical cancer	0.000146	0.000943	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGFR3—cervical cancer	0.000134	0.000865	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH1—cervical cancer	0.000126	0.000813	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH2—cervical cancer	0.000119	0.00077	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—cervical cancer	0.000115	0.000741	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH1—cervical cancer	0.000114	0.000733	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HES1—cervical cancer	9.78e-05	0.000632	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MTOR—cervical cancer	9.43e-05	0.000609	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CASP3—cervical cancer	8.67e-05	0.00056	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TERT—cervical cancer	8.57e-05	0.000554	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CTNNB1—cervical cancer	8.36e-05	0.00054	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA9—cervical cancer	8.26e-05	0.000533	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGFR3—cervical cancer	7.87e-05	0.000508	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH1—cervical cancer	7.38e-05	0.000477	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—cervical cancer	7.29e-05	0.000471	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGFR—cervical cancer	6.62e-05	0.000428	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—cervical cancer	5.56e-05	0.000359	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MTOR—cervical cancer	5.53e-05	0.000357	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASP3—cervical cancer	5.09e-05	0.000329	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CTNNB1—cervical cancer	4.91e-05	0.000317	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—cervical cancer	4.28e-05	0.000276	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGFR—cervical cancer	3.89e-05	0.000251	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—cervical cancer	3.35e-05	0.000216	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—cervical cancer	3.26e-05	0.000211	CbGpPWpGaD
